J&J COVID-19 Vaccine 66 Percent Effective in Interim Analysis
Efficacy varies by region, with 57 percent efficacy in South Africa and 72 percent efficacy in the United States
Physician’s Briefing Weekly Coronavirus Roundup
New COVID-19 Variants May Weaken Efficacy of Vaccines
But experts stress that even a weakened vaccine can still largely protect people from a severe case of COVID-19
EU Regulator Approves Oxford-AstraZeneca COVID-19 Vaccine
Vaccine is added to those made by Pfizer and Moderna, which have already been approved in the EU
Nearly Half of U.S. Adults Want the COVID-19 Vaccine as Soon as Possible
Messages about effectiveness of the vaccine and the experience of friends and family are most influential factors
Guidance Issued for COVID-19 Vaccination of Cancer Patients
Patients with cancer should be prioritized for vaccination; caregivers and household/close contacts should undergo vaccination when possible
Early Anticoagulation May Not Up Survival in Severe COVID-19
Venous thromboembolism seen in 6.3 percent and major bleeding seen in 2.8 percent of critically ill COVID-19 patients
U.S. Drug Prices 256 Percent Higher Than in 32 OECD Countries
U.S. prices higher than those in comparison countries for brand-name originator drugs, but lower for unbranded generics
Crohn Disease, Comorbidities Up Risk for Severe Pneumococcal Disease
Receipt of PCV13 alone or in combination with PPSV23 predicts fivefold reduced risk for SPD compared with no vaccination
Biden Signs Orders to Expand Health Care Access
Reopened Affordable Care Act health insurance enrollment period will run from Feb. 15 to May 15
